Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas

Annals of Surgical Oncology

Volumn 6, Issue 1, 1999, Pages 38-45

  White, Rebekah ^a   Lee, Catherine ^a   Anscher, Mitchell ^a   Gottfried, Marsha ^a   Wolff, Robert ^a   Keogan, Mary ^a   Pappas, Theodore ^a   Hurwitz, Herbert ^a   Tyler, Douglas ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoradiation; Locally advanced; Neoadjuvant; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PREOPERATIVE TREATMENT; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 0032986121     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0038-z     Document Type: Article

References (38)

1. National Cancer Institute. Annual cancer statistics review 1973-1989. National Institutes of Health Publication No. 92-2789. Bethesda, MD: U.S. Department of Health and Human Services, 1992.
2. Warshavv AL, Gu Z-Y, Whittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990;125:230-3.
3. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358-65.
4. Trede M, Schwall G, Saeger H-D. Survival after pancreaticoduodenectomy. 188 resections without an operative mortality. Ann Surg 1990;211:447-58.
5. Kaiser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-908.
6. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1980;59:2006-10.
7. Spitz FR, Abruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-37.
8. Rich TA, Evans DB. Preoperative combined modality therapy for pancreatic cancer. World J Surg 1995;19:264-9.
9. Willett CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy. Ann Surg 1993;217:144-8.
10. Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer. Ann Surg 1996;223:718-28.
11. Ihse I, Lilja P, Arnesjo B, Bengmark S. Total pancreatectomy for cancer: An appraisal of 65 cases. Ann Surg 1977;186:675-80.
12. Tryka AF, Brooks JR. Histopathology in the evaluation of total pancreatectomy for ductal carcinoma. Ann Surg 1979;190:373-81.
13. Van Heerden JA, ReMine WH, Weiland LH, McIIrath DC, Ilstrap DM. Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg 1981;142:308-11.
14. Kloppel G, Lohse T, Bosslet K, Ruckert K. Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987;2:170-5.
15. Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnkel LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977;186:42-50.
16. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418-25.
17. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124:127-32.
18. Fuhrman G, Leach SD, Staley CA, et al. Rationale for en-bloc vein resection in the treatment pancreatic adenocarcinoma adherent to the superior mesenteric-portal venous confluence. Ann Surg 1996; 223:154-62.
19. Moertel CG, Childs DS, Reitemeier RJ, Colby MY, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;1:865-7.
20. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose radiation alone, moderate dose radiation + 5-fluorouracil, and high-dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-10.
21. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-43.
22. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-733.
23. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-9.
24. Ishikawa O, Ohigashi H, Jmaoka S, et al. Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreaticoduodenectomy. Arch Surg 1991;126:885-9.
25. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 46:1945-9.
26. Huffman JP, Weese JL, Solin LJ, et al. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 1995;169:71-8.
27. Huffman JP, Weese JL, Solin LJ, et al. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. Am Surg 1993;59:772-81.
28. Yeung RS, Weese JL, Hoffman JP, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma: a phase II study. Cancer 1993;72:2124-33.
29. Hoffman SF, Lipsitz S, Pisansky T, Weese IL, Solin L, Benson AB. Phase IT Trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable, adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study. J Clin Oncol 1998;16:317-23.
30. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335-9.
31. Staley CA, Lee JE Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-25.
32. Jessup JM, Colacchio T, Valone F, et al. Phase I/II neoadjuvant trial for locally advanced pancreas adenocarcinoma. Abstract. Proc Am Soc Clin Oncol 1993;12:201.
33. Jessup JM, Steele G, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128: 559-64.
34. Wanebo HJ, Posner M, Glicksman A, Stegman M, Koness J, Vezeridis M. Integrated modality protocol for carcinoma of the pancreas: pilot program. Abstract. Proc Am Soc Clin Oncol 1991; 10:158.
35. Safran H, King TP, Choy H, et al. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer and gastric cancer: A phase I study. J Clin Oncol 1997;15:901-7.
36. Kamthan AG, Morris JC, Dalton J, et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997;15:2920-7.
37. Ellis LM, Evans DB, Martin D, Ota DM. Laparoscopic feeding jejunostomy tubes in oncology patients. Surg Oncol 1992;1:245-9.
38. Bronn D, Franklin R, Krishnan R, Richardson R, Klopp K. Increased survival rates in pancreatic cancer with concurrent continuous infusion 5-fluorouracil and cisplatin and hyperfractionated radiotherapy. Abstract. Proc Am Soc Clin Oncol 1996;15:221.